News Edwards Lifesciences Corporation Börse Stuttgart

Equities

EWL

US28176E1082

Market Closed - Börse Stuttgart Other stock markets 04:51:09 2024-06-26 EDT			5-day change	1st Jan Change
85.21 ^EUR	+1.84%		+3.65%	+20.77%

06-20	Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	MT
06-17	Edwards Lifesciences Corporation Announces Executive Changes	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Edwards Lifesciences Insider Sold Shares Worth $492,258, According to a Recent SEC Filing	06-20	MT
Edwards Lifesciences Corporation Announces Executive Changes	06-17	CI
Wolfe Research Adjusts Price Target on Edwards Lifesciences to $70 From $75	06-17	MT
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR	06-05	BU
Edwards Lifesciences Announces Results from Analysis of Data from Partner Trials Examining Outcomes of Transcatheter Aortic Valve Replacement Patients with Small Annulus	06-05	CI
Transcript : Edwards Lifesciences Corporation Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 10:30 AM	06-05
Transcript : Edwards Lifesciences Corporation Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 12:00 PM	06-04
Sector Update: Health Care Stocks Steady Premarket Monday	06-03	MT
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash	06-03	MT
Edwards Lifesciences to sell critical care products unit to Becton Dickinson for $4.2 bln	06-03	RE
Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion	06-03	MT
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader	06-03	PR
Edwards Lifesciences to Sell Critical Care to BD	06-03	BU
Becton, Dickinson and Company entered into an agreement to acquire Critical Care Product Group of Edwards Lifesciences Corporation (NYSE : EW) for $4.2 billion.	06-02	CI
Edwards Lifesciences : Charter of the Audit Committee	05-27	PU
Some of the biggest splits in Corporate America	05-23	RE
Citigroup Upgrades Edwards Lifesciences to Buy From Neutral, Adjusts Price Target to $105 From $98	05-22	MT
Edwards Lifesciences : First Quarter 2024 Fact Sheet	05-15	PU
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	05-14	MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	05-13	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Edwards Lifesciences Corporation: The story continues

April 23, 2024 at 11:25 am